Accumetrics won CE Mark approval in the European Union for its next-generation VerifyNow II System, a device designed for point-of-care measurement of platelet reactivity to antiplatelet agents.
The regulatory is a big win for Accumentrics and validation of the clinical value of platelet reactivity testing, according to the company, which expects to expand market opportunities for the VerifyNow System in surgical and interventional cardiology patients, according to the press release.